Barclays PLC Vista Gen Therapeutics, Inc. Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.12 - $0.3 $5,947 - $14,868	49,562 Added 89.19%	105,128 $13,000
Q4 2022 Feb 13, 2023	BUY	$0.09 - $4.8 $4,257 - $227,088	47,310 Added 573.04%	55,566 $6,000
Q3 2022 Nov 03, 2022	SELL	$0.14 - $4.8 $212 - $7,286	-1,518 Reduced 15.53%	8,256 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $19,117 - $37,582	-21,724 Reduced 68.97%	9,774 $9,000
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $232,577 - $426,391	-204,015 Reduced 86.63%	31,498 $40,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $260,715 - $430,882	156,117 Added 196.63%	235,513 $459,000
Q3 2021 Nov 09, 2021	BUY	$2.62 - $3.45 $144,595 - $190,402	55,189 Added 227.99%	79,396 $218,000
Q2 2021 Aug 13, 2021	BUY	$1.96 - $3.15 $7,908 - $12,710	4,035 Added 20.0%	24,207 $76,000
Q1 2021 May 13, 2021	BUY	$1.89 - $2.96 $38,125 - $59,709	20,172 New	20,172 $43,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.